Evidence map›Paper›PMID 26546161›Full record

ArticleMalaria journal2015

The influence of intestinal parasites on Plasmodium vivax-specific antibody responses to MSP-119 and AMA-1 in rural populations of the Brazilian Amazon.

Juan Camilo Sánchez-Arcila, Marcelle Marcolino de França, Virginia Araujo Pereira, Mariana Pinheiro Alves Vasconcelos, Antonio Têva, Daiana de Souza Perce-da-Silva, Joffre Rezende Neto, Cesarino Junior Lima Aprígio, Josue da Costa Lima-Junior, Mauricio Martins Rodrigues and 3 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Epidemiological characteristics ofFrontiers in cellular and infection microbiology · 2022
    Article
  4. Antibodies Against theFrontiers in cellular and infection microbiology · 2021
    Article
  5. Diagnostic Methods for Non-Falciparum Malaria.Frontiers in cellular and infection microbiology · 2021
    Review
  6. Antibody Responses AgainstFrontiers in immunology · 2019
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Juan Camilo Sánchez-ArcilaLaboratorio de Imunoparasitologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, Brazil. jucasaar@ioc.fiocruz.br.
Marcelle Marcolino de FrançaLaboratorio de Imunoparasitologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, Brazil. marcelle.mf@gmail.com.
Virginia Araujo PereiraLaboratorio de Imunoparasitologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, Brazil. virginia@ioc.fiocruz.br.
Mariana Pinheiro Alves VasconcelosInstituto de Infectologia Emílio Ribas, São Paulo, Brazil. marianapvasconcelos@hotmail.com.
Antonio TêvaLaboratório de Imunodiagnóstico, Departamento de Ciências Biológicas, Escola Nacional de Saúde Pública/Fiocruz, Rio de Janeiro, Brazil. teva@ioc.fiocruz.br.
Daiana de Souza Perce-da-SilvaLaboratório de Simulídeos e Oncocercose, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. daiana@ioc.fiocruz.br.
Joffre Rezende NetoIntituto de Gastroenterologia de Goiânia, Goiânia, Goiás, Brazil. joffre_neto@terra.com.br.
Cesarino Junior Lima AprígioAgencia de Vigilância em Saúde da Secretaria de Estado da Saúde - AGEVISA, Rondonia, Brazil. cesarinovet@hotmail.com.
Josue da Costa Lima-JuniorLaboratorio de Imunoparasitologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, Brazil. josue@ioc.fiocruz.br.
Mauricio Martins RodriguesCentro de Terapia Celular e Molecular (CTCMol), Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, Brazil. mrodrigues@unifesp.br.
Irene Silva SoaresDepartamento de Análises Clínicas e Toxicológicas, Faculdadede Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, Brazil. isoares@usp.br.
Dalma Maria BanicLaboratório de Simulídeos e Oncocercose, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. banic@ioc.fiocruz.br.
Joseli Oliveira-FerreiraLaboratorio de Imunoparasitologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Av. Brasil 4365, Manguinhos, Rio de Janeiro, Brazil. lila@ioc.fiocruz.br.
Fundação Oswaldo Cruz · BREscola Nacional de Saúde Pública · BRInstituto de Gastroenterologia de Goiânia · BRInstituto de Infectologia Emílio Ribas · BRSecretaria da Saúde · BRUniversidade de São Paulo · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPolyparasitism is a common condition in humans but its impact on the host immune system and clinical diseases is still poorly understood. There are few studies of the prevalence and the effect of malaria-intestinal parasite co-infections in the immune response to malaria vaccine candidates. The present study determines whether the presence of malaria and intestinal parasites co-infection is associated with impaired IgG responses to Plasmodium vivax AMA-1 and MSP-119 in a rural population of the Brazilian Amazon.

methodsA cross-sectional survey was performed in a rural area of Rondonia State and 279 individuals were included in the present study. At recruitment, whole blood was collected and Plasmodium and intestinal parasites were detected by microscopy and molecular tests. Blood cell count and haemoglobin were also tested and antibody response specific to P. vivax AMA-1 and MSP-119 was measured in plasma by ELISA. The participants were grouped according to their infection status: singly infected with Plasmodium (M); co-infected with Plasmodium and intestinal parasites (CI); singly infected with intestinal parasites (IP) and negative (N) for both malaria and intestinal parasites.

resultsThe prevalence of intestinal parasites was significantly higher in individuals with malaria and protozoan infections were more prevalent. IgG antibodies to PvAMA-1 and/or PvMSP-119 were detected in 74 % of the population. The prevalence of specific IgG was similar for both proteins in all four groups and among the groups the lowest prevalence was in IP group. The cytophilic sub-classes IgG1 and IgG3 were predominant in all groups for PvAMA-1 and IgG1, IgG3 and IgG4 for PvMSP-119. In the case of non-cytophilic antibodies to PvAMA-1, IgG2 was significantly higher in IP and N group when compared to M and CI while IgG4 was higher in IP group.

conclusionsThe presence of intestinal parasites, mainly protozoans, in malaria co-infected individuals does not seem to alter the antibody immune responses to P. vivax AMA-1 and MSP-119. However, IgG response to both AMA1 and MSP1 were lower in individuals with intestinal parasites.

Indexed as

AdultAntigens, ProtozoanBrazilCoinfectionHumansImmunoglobulin GIntestinal Diseases, ParasiticMalariaMembrane ProteinsMerozoite Surface Protein 1Plasmodium vivaxPrevalenceProtozoan ProteinsYoung AdultAntigens, Protozoanapical membrane antigen I, PlasmodiumImmunoglobulin GMembrane ProteinsMerozoite Surface Protein 1Protozoan Proteins

Identifiers

PMID26546161
PMCPMC4636833
OpenAlexW2131476645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.